English | Español

Biospace
Patient Daily | Mar 22, 2026

Pfizer reports phase 2 trial results for Ibrance successor in breast cancer treatment
Patient Daily | Mar 22, 2026

AI drug discovery platforms face new challenges in attracting investors
Patient Daily | Mar 22, 2026

Astellas ends partnership with CytomX despite positive early cancer drug data
Patient Daily | Mar 22, 2026

Rhythm’s Imcivree fails to meet main goal in late-stage obesity trial
Patient Daily | Mar 22, 2026

FDA issues third rejection for Aldeyra’s dry eye disease drug on March 17
Patient Daily | Mar 22, 2026

Federal judge blocks Kennedy’s vaccine policy overhaul, citing procedural failures
Patient Daily | Mar 22, 2026

FDA expands leucovorin use for rare disease amid scrutiny of regulatory standards
Patient Daily | Mar 22, 2026

Excalipoint Therapeutics announces $68.7 million seed funding for cancer immunotherapy pipeline

Trending
+ Marketing
A. K. Abreu | Jun 9, 2026

Patient in 5.0 Google review: Gulf Coast Breathe Free Sinus & Allergy Centers ‘changed my life’
Patient Daily | Jun 5, 2026

National Breathe Free donates $175,000 to support shelter for Tampa Bay families
+ Regulatory
Patient Daily News Service | Jun 9, 2026

New colon cancer blood test wins Medicare coverage, but trails stool-based screening in detecting precancerous lesions
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

FDA rare disease framework faces uncertainty after leadership departures